The increase of pseudomonas aeroginosa positivity in samples from patients carrying the novo coronavirus

Authors

DOI:

https://doi.org/10.33448/rsd-v11i10.19040

Keywords:

Pseudomonas aeruginosa; Disinfection; COVID-19; Health.

Abstract

In 2019, the first cases of the new virus in the world began, in the city of Wuhan, China. As it is easy to spread, it quickly arrived in Brazil in February 2020, being declared a pandemic. The virus is transmitted through the airways, so new methods were used for possible control of the disease. This work intends to evaluate articles that talk about the prevalence of Pseudomonas aeruginosa in samples of patients with the new coronavirus, in order to present this prevalence so that they can be analyzed and used for future publications. All publications that had data on the prevalence of Pseudomonas aeroginosa in samples of patients with the new coronavirus, scientific publications, official publications of the World Health Organization (WHO) and government, within a given date (2019-2021) were used. Data were collected using the following scientific databases: Latin American and Caribbean Literature on Health Sciences (LILACS), National Library of Medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library – (BVS), Scientific Electronic Library Online (SCIELO), Cochrane Library, HighWire Press, Scopus and Elsevier. A total of 3,011 articles were found (Table 1) in the scientific databases: Latin American and Caribbean Literature on Health Sciences (LILACS), National Library of Medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library – (BVS), Scientific Electronic Library Online (SCIELO), Cochrane Library, HighWire Press, Scopus and Elsevier. The following descriptors were used: Pseudomonas aeruginosa, HOSPITAL INFECTION, SARS-COV-2, COVID 19 in English, Portuguese and Spanish. Based on the results of this research, we saw that there is a greater need for the creation of standardization of protocols, for the reduction of cases and also for cleaning. We need more work and research for data renewal and a greater update for the population.

References

Chughtai, A. A., Seale, H., Islam, M. S., Owais, M., Macintyre, C. R. (2020). Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19). Int J Nurs Stud; 105:103567.

Clinical and Laboratory Standards Institute. (2021). Performance Standards for Antimicrobial Susceptibility Testing, 31st edition. Supplement M100. Pittsburgh, PA: CLSI.

Costa, D. B., Ramos, D., Gabriel, C. S., Bernardes, A. (2018). Patient safety culture: evaluation by nursing professionals. Texto Contexto Enfermagem [Internet].

Da Cunha, R. S. R., Carniel, E., Narvaez, G. A., Dias, C. G., Perez, L. R. R. (2021). Impact of the blue-carba rapid test for carbapenemase detection on turnaround time for an early therapy against Pseudomonas aeruginosa. Am J Infect Control; 49:352–354.

Ferioli, M., Cisternino, C., Leo, V., Pisani, L., Palange, P., Nava, S. (2020). Protegendo os profissionais de saúde da infecção por SARS-CoV-2: indicações práticas. Eur Respir R. 29(155): 200068.

Galetti, R., Andrade, L. N., Varani, A. M., Darini, A. L. C. S. P. M. (2019).1–producing Pseudomonas aeruginosa ST277 carries a chromosomal pack of acquired resistance genes: an example of high-risk clone associated with 'intrinsic resistome'. J Glob Antimicrob Resist 2019; 16:183–186.

Gallasch, C. H., Cunha, M. L., Pereira, L. A. S., Silva-Junior, J. S. (2020). Prevenção relacionada à exposição ocupacional do profissional de saúde no cenário de COVID-19. Rev enferm UERJ. 28:e49596.

Gaudereto, J. J., Perdigão, Neto, L. V., Leite, G. C., et al. (2019). Synergistic effect of ceftazidime-avibactam with meropenem against panresistant, carbapenemase-harboring Acinetobacter baumannii and Serratia marcescens investigated using time-kill and disk approximation assays. Antimicrob Agents Chemother. 63:e02367–18.

Hopkins, J. (2020). New Cases of COVID-19 In World Countries. University and medicine. [Internet].

Khan, A., Shropshire, W. C., Hanson, B., et al. (2020). Simultaneous infection with Enterobacteriaceae and Pseudomonas aeruginosa harboring multiple carbapenemases in a returning traveler colonized with Candida auris. Antimicrob Agents Chemother. 64:e01466–19.

Linciano, P., Cendron, L., Gianquinto, E., Spyrakis, F., Tondi, D. (2019). Ten Years with New Delhi metallo-beta-lactamase-1 (NDM-1): from structural insights to inhibitor design. ACS Infect Dis. 5:9–34.

Livermore, D. (1992). Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 36:2046–2048.

Marshall, S., Hujer, A. M., Rojas, L. J., et al. (2017). Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae? Antimicrob Agents Chemother. 61:e02243–16.

Miranda, V. S. G., Rech, R. S., Maahs, M. A. P. (2020). Relatos. Revista Enfermagem ATUAL IN Derme | Edição Especial Covid19. e-020013.

NOTA TÉCNICA GVIMS/GGTES/ANVISA Nº 07/2020 Orientações para prevenção e vigilância epidemiológica das infecções por SARS-COV-2 (Covid- 19) dentro dos serviços de saúde.

Organização Pan-americana da Saúde (OPAS). (2020). Folha informativa – COVID-19 (doença causada pelo novo coronavírus) [Internet]. Brasília.

Perez, F, El Chakhtoura, N. G., Pappwallace, K. M., Wilson, B. M., Bonomo, R. A. (2016). Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy? Expert Opin Pharmacother. 17:761–781.

Poole, K. (2011). Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2:65.

World Health Organization. (2019b). Report of the WHO-China Joint Mission on Coronavirus Disease. (COVID-19).

World Health Organization. (2019a). Rolling updates on coronavirus disease (COVID-19).

Published

31/07/2022

How to Cite

SILVA, K. M. R. da .; SÁ , L. F. P. de .; MATA, J. P. de O. .; TEIXEIRA , A. da S. .; CRISANTO, A. V. S. de M. S. .; AMORIM, G. R. .; PINHEIRO, F. P. .; MARTINS, L. A.; SILVA , Ícaro A. .; OLIVEIRA, A. P. de .; AGUIAR, M. P. de Q. .; AGUIAR, U. N. de .; GONÇALVES, W. V. E. .; SILVA, A. M. da .; FERREIRA, K. L. C. . The increase of pseudomonas aeroginosa positivity in samples from patients carrying the novo coronavirus. Research, Society and Development, [S. l.], v. 11, n. 10, p. e05111019040, 2022. DOI: 10.33448/rsd-v11i10.19040. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/19040. Acesso em: 3 oct. 2022.

Issue

Section

Health Sciences